§ PHARMACEUTICALS
USD · PharmaceuticalsGSK
GSK PLC-SPON ADR
USDSector · PharmaceuticalsBeta · 1.13
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
OPEN 46.87HIGH 46.88LOW 46.3352W 1242.50 — 2282.00
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
499 increased/new, 356 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/E | 15.0 | P/B | 4.51 |
| EPS (TTM) | 1.39 | Dividend | 3.42% |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Fidelity Management | 67.7M | 0.2% | +0% |
| Dodge & Cox | 58.7M | 1.8% | −14% |
| Fisher Asset Management, LLC | 34.5M | 0.6% | +4% |
| PRIMECAP MANAGEMENT CO/CA/ | 25.2M | 1.1% | +0% |
| WELLINGTON MANAGEMENT GROUP LLP | 11.7M | 0.1% | −7% |
| Morgan Stanley | 11.0M | 0.0% | −5% |
◇ AC INTELLIGENCE
Top institutional owners for GSK as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER90.6% · 0 holders
QUALITY / COMPOUNDER3.3% · 23 holders
OTHER2.8% · 894 holders
DEEP VALUE1.5% · 4 holders
DEALER / BANK1.3% · 85 holders
PASSIVE / INDEX0.1% · 7 holders
SYSTEMATIC / QUANT0.1% · 13 holders
INCOME / DEFENSIVE0.1% · 9 holders
TACTICAL / MACRO0.1% · 4 holders
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for GSK in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention GSK yet.